108 related articles for article (PubMed ID: 29212169)
1. CCCTC-binding factor inhibits breast cancer cell proliferation and metastasis via inactivation of the nuclear factor-kappaB pathway.
Wu J; Li PC; Pang JY; Liu GY; Xie XM; Li JY; Yin YC; Han JH; Guo XZ; Qiu L
Oncotarget; 2017 Nov; 8(55):93516-93529. PubMed ID: 29212169
[TBL] [Abstract][Full Text] [Related]
2. A negative feedback loop between miR-200b and the nuclear factor-κB pathway via IKBKB/IKK-β in breast cancer cells.
Wu H; Wang G; Wang Z; An S; Ye P; Luo S
FEBS J; 2016 Jun; 283(12):2259-71. PubMed ID: 26433127
[TBL] [Abstract][Full Text] [Related]
3. NF-kappa B mediated up-regulation of CCCTC-binding factor in pediatric acute lymphoblastic leukemia.
Zhang H; Zhu L; He H; Zhu S; Zhang W; Liu X; Zhao X; Gao C; Mei M; Bao S; Zheng H
Mol Cancer; 2014 Jan; 13():5. PubMed ID: 24393203
[TBL] [Abstract][Full Text] [Related]
4. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis.
Song L; Liu D; Zhao Y; He J; Kang H; Dai Z; Wang X; Zhang S; Zan Y
Biochem Biophys Res Commun; 2015 Aug; 464(3):705-10. PubMed ID: 26166821
[TBL] [Abstract][Full Text] [Related]
5. NF-kappaB subtypes regulate CCCTC binding factor affecting corneal epithelial cell fate.
Lu L; Wang L; Li T; Wang J
J Biol Chem; 2010 Mar; 285(13):9373-9382. PubMed ID: 20110362
[TBL] [Abstract][Full Text] [Related]
6. CTCF promotes epithelial ovarian cancer metastasis by broadly controlling the expression of metastasis-associated genes.
Zhao L; Yang Y; Yin S; Yang T; Luo J; Xie R; Long H; Jiang L; Zhu B
Oncotarget; 2017 Sep; 8(37):62217-62230. PubMed ID: 28977939
[TBL] [Abstract][Full Text] [Related]
7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression.
Sovak MA; Arsura M; Zanieski G; Kavanagh KT; Sonenshein GE
Cell Growth Differ; 1999 Aug; 10(8):537-44. PubMed ID: 10470853
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
[TBL] [Abstract][Full Text] [Related]
11. 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.
Tse AK; Zhu GY; Wan CK; Shen XL; Yu ZL; Fong WF
Mol Immunol; 2010 May; 47(9):1728-38. PubMed ID: 20371119
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells.
Rahman KW; Sarkar FH
Cancer Res; 2005 Jan; 65(1):364-71. PubMed ID: 15665315
[TBL] [Abstract][Full Text] [Related]
13. CTCF negatively regulates HOXA10 expression in breast cancer cells.
Mustafa M; Lee JY; Kim MH
Biochem Biophys Res Commun; 2015 Nov; 467(4):828-34. PubMed ID: 26478432
[TBL] [Abstract][Full Text] [Related]
14. Mutation of isocitrate dehydrogenase 1 induces glioma cell proliferation via nuclear factor-κB activation in a hypoxia-inducible factor 1-α dependent manner.
Wang G; Sai K; Gong F; Yang Q; Chen F; Lin J
Mol Med Rep; 2014 May; 9(5):1799-805. PubMed ID: 24626950
[TBL] [Abstract][Full Text] [Related]
15. Ganoderic acids suppress growth and angiogenesis by modulating the NF-κB signaling pathway in breast cancer cells.
Li F; Wang Y; Wang X; Li J; Cui H; Niu M
Int J Clin Pharmacol Ther; 2012 Oct; 50(10):712-21. PubMed ID: 22762853
[TBL] [Abstract][Full Text] [Related]
16. Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1.
Rakha EA; Pinder SE; Paish CE; Ellis IO
Br J Cancer; 2004 Oct; 91(8):1591-6. PubMed ID: 15354217
[TBL] [Abstract][Full Text] [Related]
17. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
18. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of metallopanstimulin-1 inhibits NF-κB signaling at different levels: the role of apoptosis induction of gastric cancer cells.
Yang ZY; Qu Y; Zhang Q; Wei M; Liu CX; Chen XH; Yan M; Zhu ZG; Liu BY; Chen GQ; Wu YL; Gu QL
Int J Cancer; 2012 Jun; 130(12):2761-70. PubMed ID: 21796632
[TBL] [Abstract][Full Text] [Related]
20. Depletion of CTCF in Breast Cancer Cells Selectively Induces Cancer Cell Death via p53.
Lee JY; Mustafa M; Kim CY; Kim MH
J Cancer; 2017; 8(11):2124-2131. PubMed ID: 28819414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
